RenovaCare Inc. appointed Harmel Rayat, a majority stockholder, as board chairman.

Rayat is an entrepreneur-investor, whose portfolio includes class A commercial properties in the U.S. and Canada. He has invested nearly $6 million in RenovaCare and its stem cell spray technologies.

New York-based RenovaCare is a development-stage company, which focuses on the acquisition, research, development and commercialization of autologous cellular therapies for use in medical and aesthetic applications.